Successful treatment with three-weekly paclitaxel of an anthracycline-refractory classical Kaposi's sarcoma.
Copyright policy )Successful treatment with three-weekly paclitaxel of an anthracycline-refractory classical Kaposi's sarcoma.
Paclitaxel has been approved as second-line therapy after anthracyclines in AIDS-Kaposi's sarcoma (KS) patients. To date, only one patient with classical KS and treated with standard dose (175 mg/m2) 3-weekly paclitaxel as first line therapy has been reported in the literature. Herein, the first case is presented of a patient with anthracycline-refractory classical KS who was treated with standard dose 3-weekly and paclitaxel after five cycles of therapy achieved a partial response according to the AIDS Clinical Trials Group criteria.
- University of Messina Italy
- University of Bari Aldo Moro Italy
Aged, 80 and over, Male, Paclitaxel, Drug Resistance, Antineoplastic Agents, Sarcoma, Kaposi, Anthracycline, Antineoplastic Agents, Phytogenic, Drug Administration Schedule, Aged, 80 and over, Anthracyclines, Antineoplastic Agents, Phytogenic, Drug Administration Schedule, Drug Resistance, Neoplasm, Humans, Male, Paclitaxel, Sarcoma Kaposi, Drug Resistance, Neoplasm, Phytogenic, 80 and over, Neoplasm, Humans, Anthracyclines, Sarcoma, Kaposi, Aged, Human
Aged, 80 and over, Male, Paclitaxel, Drug Resistance, Antineoplastic Agents, Sarcoma, Kaposi, Anthracycline, Antineoplastic Agents, Phytogenic, Drug Administration Schedule, Aged, 80 and over, Anthracyclines, Antineoplastic Agents, Phytogenic, Drug Administration Schedule, Drug Resistance, Neoplasm, Humans, Male, Paclitaxel, Sarcoma Kaposi, Drug Resistance, Neoplasm, Phytogenic, 80 and over, Neoplasm, Humans, Anthracyclines, Sarcoma, Kaposi, Aged, Human
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).4 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!